We are using cookies This website uses cookies in order to offer you the most relevant information. By browsing this website, you accept these cookies.
Lundbeck currently generates the majority of its revenue from Cipralex, sold in the United States as Lexapro.
2
Lundbeck currently generates most of its revenue from antidepressant Cipralex, sold in the United States as Lexapro.
3
Cipralex sales were 990 million crowns, above the average estimate of 982 million crowns.
4
Lundbeck generates most of its revenue from antidepressant Cipralex, sold as Lexapro in the United States by Forest Laboratories.
5
Lundbeck, which currently generates the majority of its revenue from Cipralex, sold in the United States as Lexapro, said it would appeal against the decision.
6
Lundbeck reported Cipralex sales of 1.0 billion crowns in the quarter, up 20 percent, while Lexapro sales rose 47 percent to 641 million crowns.
7
Lundbeck generates the majority of its revenues from Lexapro, sold outside the United States as Cipralex, and the patents for the drug expire in 2012-2014.